136 related articles for article (PubMed ID: 9245550)
1. Effects of sialadenitis after cellular transfer in autoimmune MRL/lpr mice.
Skarstein K; Johannessen AC; Holmdahl R; Jonsson R
Clin Immunol Immunopathol; 1997 Aug; 84(2):177-84. PubMed ID: 9245550
[TBL] [Abstract][Full Text] [Related]
2. Biased T cell receptor V beta gene usage during specific stages of the development of autoimmune sialadenitis in the MRL/lpr mouse model of Sjögren's syndrome.
Hayashi Y; Hamano H; Haneji N; Ishimaru N; Yanagi K
Arthritis Rheum; 1995 Aug; 38(8):1077-84. PubMed ID: 7639803
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of Sjögren's syndrome-like autoimmune lesions in MRL/lpr mice.
Hayashi Y; Haneji N; Hamano H
Pathol Int; 1994 Aug; 44(8):559-68. PubMed ID: 7952145
[TBL] [Abstract][Full Text] [Related]
4. Sjögren's syndrome-like autoimmune sialadenitis in MRL-Faslpr mice is associated with expression of glucocorticoid-induced TNF receptor-related protein (GITR) ligand and 4-1BB ligand.
Saito K; Mori S; Date F; Ono M
Autoimmunity; 2013 Jun; 46(4):231-7. PubMed ID: 23301790
[TBL] [Abstract][Full Text] [Related]
5. Epigallocatechin gallate stimulates the neuroreactive salivary secretomotor system in autoimmune sialadenitis of MRL-Fas(lpr) mice via activation of cAMP-dependent protein kinase A and inactivation of nuclear factor κB.
Saito K; Mori S; Date F; Hong G
Autoimmunity; 2015; 48(6):379-88. PubMed ID: 25847253
[TBL] [Abstract][Full Text] [Related]
6. Impact of gender on exocrine gland inflammation in mouse models of Sjögren's syndrome.
Toda I; Sullivan BD; Rocha EM; Da Silveira LA; Wickham LA; Sullivan DA
Exp Eye Res; 1999 Oct; 69(4):355-66. PubMed ID: 10504269
[TBL] [Abstract][Full Text] [Related]
7. Effects of immunomodulating treatment on autoimmune sialadenitis in MRL/Mp-lpr/lpr mice.
Jonsson R; Tarkowski A; Bäckman K
Agents Actions; 1988 Dec; 25(3-4):368-74. PubMed ID: 3218611
[TBL] [Abstract][Full Text] [Related]
8. Antagonist of interferon-inducible protein 10/CXCL10 ameliorates the progression of autoimmune sialadenitis in MRL/lpr mice.
Hasegawa H; Inoue A; Kohno M; Muraoka M; Miyazaki T; Terada M; Nakayama T; Yoshie O; Nose M; Yasukawa M
Arthritis Rheum; 2006 Apr; 54(4):1174-83. PubMed ID: 16575871
[TBL] [Abstract][Full Text] [Related]
9. Role of T cells in the pathogenesis of autoimmune lacrimal gland disease in MRL/Mp-lpr/lpr mice.
Jabs DA; Lee B; Prendergast RA
Curr Eye Res; 1997 Sep; 16(9):909-16. PubMed ID: 9288452
[TBL] [Abstract][Full Text] [Related]
10. Transfer of Sjögren's syndrome-like autoimmune lesions into SCID mice and prevention of lesions by anti-CD4 and anti-T cell receptor antibody treatment.
Hayashi Y; Haneji N; Hamano H; Yanagi K
Eur J Immunol; 1994 Nov; 24(11):2826-31. PubMed ID: 7957574
[TBL] [Abstract][Full Text] [Related]
11. Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjögren's syndrome.
Zoukhri D; Kublin CL
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):925-32. PubMed ID: 11274068
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin gallate inhibits oxidative stress-induced DNA damage and apoptosis in MRL-Fas(lpr) mice with autoimmune sialadenitis via upregulation of heme oxygenase-1 and Bcl-2.
Saito K; Mori S; Date F; Ono M
Autoimmunity; 2014 Feb; 47(1):13-22. PubMed ID: 24392721
[TBL] [Abstract][Full Text] [Related]
13. Treatment of chronic sialadenitis in a murine model of Sjögren's syndrome by local fasL gene transfer.
Fleck M; Zhang HG; Kern ER; Hsu HC; Müller-Ladner U; Mountz JD
Arthritis Rheum; 2001 Apr; 44(4):964-73. PubMed ID: 11315936
[TBL] [Abstract][Full Text] [Related]
14. Low-intensity pulsed ultrasound rescues insufficient salivary secretion in autoimmune sialadenitis.
Sato M; Kuroda S; Mansjur KQ; Khaliunaa G; Nagata K; Horiuchi S; Inubushi T; Yamamura Y; Azuma M; Tanaka E
Arthritis Res Ther; 2015 Oct; 17():278. PubMed ID: 26445930
[TBL] [Abstract][Full Text] [Related]
15. Oligoclonality of T cells in salivary glands of autoimmune MRL/lpr mice.
Skarstein K; Holmdahl R; Johannessen AC; Jonsson R
Immunology; 1994 Apr; 81(4):497-501. PubMed ID: 8039804
[TBL] [Abstract][Full Text] [Related]
16. Expression of heterozygous lpr gene in MRL mice. II. Acceleration of glomerulonephritis, sialadenitis, and autoantibody production.
Carlsten H; Tarkowski A; Jonsson R; Nilsson LA
Scand J Immunol; 1990 Jul; 32(1):21-8. PubMed ID: 2382106
[TBL] [Abstract][Full Text] [Related]
17. In vivo role of IL-10 and IL-12 during development of Sjögren's syndrome in MRL/lpr mice.
Yanagi K; Haneji N; Hamano H; Takahashi M; Higashiyama H; Hayashi Y
Cell Immunol; 1996 Mar; 168(2):243-50. PubMed ID: 8640871
[TBL] [Abstract][Full Text] [Related]
18. Prevention of adoptive transfer of murine Sjögren's syndrome into severe combined immunodeficient (SCID) mice by antibodies against intercellular adhesion molecule-1 (ICAM-1) and lymphocyte function-associated antigen-1 (LFA-1).
Hayashi Y; Haneji N; Yanagi K; Higashiyama H; Yagita H; Hamano H
Clin Exp Immunol; 1995 Nov; 102(2):360-7. PubMed ID: 7586691
[TBL] [Abstract][Full Text] [Related]
19. Local IgA and IgM rheumatoid factor production in autoimmune MRL/lpr mice.
Jonsson R; Pitts A; Mestecky J; Koopman W
Autoimmunity; 1991; 10(1):7-14. PubMed ID: 1742425
[TBL] [Abstract][Full Text] [Related]
20. Salivary-gland-protective regulatory T-cell dysfunction underlies female-specific sialadenitis in the non-obese diabetic mouse model of Sjögren syndrome.
Barr JY; Wang X; Kreiger PA; Lieberman SM
Immunology; 2018 Oct; 155(2):225-237. PubMed ID: 29750331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]